Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M103,998Revenue (TTM) $M37,719Net Margin (%)12.3Altman Z-Score1.9
Enterprise Value $M116,632EPS (TTM) $1.8Operating Margin %14.6Piotroski F-Score7
P/E(ttm)23.8Beneish M-Score-3.6Pre-tax Margin (%)13.5Higher ROA y-yN
Price/Book1.810-y EBITDA Growth Rate %--Quick Ratio1.0Cash flow > EarningsY
Price/Sales2.95-y EBITDA Growth Rate %-4.3Current Ratio1.5Lower Leverage y-yY
Price/Free Cash Flow16.4y-y EBITDA Growth Rate %-2.7ROA % (ttm)4.2Higher Current Ratio y-yN
Dividend Yield %4.1PEG--ROE % (ttm)7.5Less Shares Outstanding y-yY
Payout Ratio %92.0Shares Outstanding M2,574ROIC % (ttm)6.7Gross Margin Increase y-yY

Gurus Latest Trades with SNY

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SNYBill Nygren 2016-09-30 Reduce-0.67%$37.83 - $42.63
($40.13)
$ 40.401%Reduce -42.05%3,170,000
SNYNWQ Managers 2016-09-30 Buy 0.19%$37.83 - $42.63
($40.13)
$ 40.401%New holding335,521
SNYBarrow, Hanley, Mewhinney & Strauss 2016-09-30 Add0.19%$37.83 - $42.63
($40.13)
$ 40.401%Add 11.37%31,320,327
SNYDodge & Cox 2016-09-30 Add0.15%$37.83 - $42.63
($40.13)
$ 40.401%Add 7.45%59,267,298
SNYHOTCHKIS & WILEY 2016-09-30 Add0.1%$37.83 - $42.63
($40.13)
$ 40.401%Add 5.33%12,041,028
SNYKen Fisher 2016-09-30 Reduce-0.1%$37.83 - $42.63
($40.13)
$ 40.401%Reduce -8.76%12,443,197
SNYCharles Brandes 2016-09-30 Reduce-0.03%$37.83 - $42.63
($40.13)
$ 40.401%Reduce -1.19%3,557,856
SNYJohn Paulson 2016-09-30 Add0.01%$37.83 - $42.63
($40.13)
$ 40.401%Add 5.44%417,000
SNYJoel Greenblatt 2016-09-30 Reduce$37.83 - $42.63
($40.13)
$ 40.401%Reduce -7.57%32,879
SNYNWQ Managers 2016-06-30 Sold Out -1.22%$38.13 - $44.32
($40.99)
$ 40.40-1%Sold Out0
SNYDavid Dreman 2016-06-30 Add0.47%$38.13 - $44.32
($40.99)
$ 40.40-1%Add 980.43%20,204
SNYHOTCHKIS & WILEY 2016-06-30 Add0.23%$38.13 - $44.32
($40.99)
$ 40.40-1%Add 12.47%11,432,112
SNYJohn Paulson 2016-06-30 Buy 0.17%$38.13 - $44.32
($40.99)
$ 40.40-1%New holding395,500
SNYDodge & Cox 2016-06-30 Add0.07%$38.13 - $44.32
($40.99)
$ 40.40-1%Add 3.04%55,155,913
SNYBarrow, Hanley, Mewhinney & Strauss 2016-06-30 Reduce-0.06%$38.13 - $44.32
($40.99)
$ 40.40-1%Reduce -3.32%28,122,279
SNYCharles Brandes 2016-06-30 Add0.03%$38.13 - $44.32
($40.99)
$ 40.40-1%Add 1.24%3,600,731
SNYKen Fisher 2016-06-30 Add0.01%$38.13 - $44.32
($40.99)
$ 40.40-1%Add 0.67%13,638,183
SNYJoel Greenblatt 2016-06-30 Add$38.13 - $44.32
($40.99)
$ 40.40-1%Add 2.45%35,571
SNYCharles Brandes 2016-03-31 Add0.78%$38.37 - $42.65
($40.17)
$ 40.401%Add 61.76%3,556,721
SNYDodge & Cox 2016-03-31 Add0.14%$38.37 - $42.65
($40.17)
$ 40.401%Add 7.24%53,530,129
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SNY is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


SNY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Sanofi10% Owner 2015-01-29Buy97,118$95-58.14view
Sanofi10% Owner 2015-01-26Buy647,448$95-58.14view
Sanofi10% Owner 2015-01-22Buy196,251$93.17-57.31view
Sanofi10% Owner 2014-03-25Buy344,448$66.88-40.54view
Sanofi10% Owner 2014-02-04Buy1,303,780$7.67418.51view

Press Releases about SNY :

Quarterly/Annual Reports about SNY:

    News about SNY:

    Articles On GuruFocus.com
    Warren Buffett’s Only Dividend Stocks With 4%-Plus Yields Nov 29 2016 
    World Leader in Diabetes Medication Hits 2-Year Low Nov 07 2016 
    First Eagle Investments Comments on Sanofi Oct 24 2016 
    Gilead’s Patience Is Wearing Investors' Patience Thin Oct 10 2016 
    Novo Nordisk Is Being Ignored Oct 06 2016 
    Take a Look at Sanofi Oct 05 2016 
    John Paulson Trims Synergy Sep 23 2016 
    Buffett Stock Wells Fargo Falls to 52-Week Low After Scandal Sep 22 2016 
    Sanofi Sues Merck Over Patent Infringement Sep 20 2016 
    Sanofi in a State of Suspended Animation Until Boehringer Ingelheim Swap Sep 19 2016 

    More From Other Websites
    Biotechs 'Round-Trip' Trump-Inspired Rally; FDA Appointment Key Dec 08 2016
    EU Regulators Will Review Regeneron's Eczema Drug Dec 08 2016
    Regeneron and Sanofi Announce Marketing Authorization Application for Dupixent® (dupilumab)... Dec 08 2016
    Actelion Is a Perfect Fit for Sanofi, but Probably Too Expensive: Exane BNP Dec 07 2016
    Sanofi May Battle Johnson & Johnson For European Biotech Actelion Dec 06 2016
    Sanofi SA (ADR) (SNY) Could Challenge Johnson & Johnson (JNJ) Bid For Actelion Ltd (ALIOF) Dec 06 2016
    Big Pharma, Short on Blockbusters, Outsources the Science Dec 06 2016
    Sanofi Said to Weigh Actelion Bid Challenging J&J Dec 06 2016
    Sanofi Said to Weigh Actelion Bid Challenging J&J Dec 06 2016
    Stocks Open Slightly Lower; Boeing Dips On Trump Tweet Dec 06 2016
    5 Things You Must Know Before the Market Opens Tuesday Dec 06 2016
    Sanofi Must Pick Its Battle Dec 06 2016
    European Stocks Slip Lower, Italy Gains in Mixed Start to Trading Dec 06 2016
    Actelion Surges on Report of Sanofi Challenge to J&J Takeover Bid Dec 06 2016
    Sanofi exploring bid for Actelion amid J&J talks - Bloomberg Dec 05 2016
    Sanofi exploring bid for Actelion amid J&J talks - Bloomberg Dec 05 2016
    Sanofi to Explore Counterbid for Actelion Amid J&J Talks Dec 05 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)